Data from various retinal clinical trials suggest that there is a difference in efficacy in anti-VEGF therapies for patients ...

ALAN CARR fears an eye condition will ruin his eyesight after having a “worrying” diagnostic test. The 48-year-old Chatty Man ...

Glaucoma Treatment MarketThe global glaucoma treatment market, valued at USD 5.7 billion in 2022, is projected to grow at a CAGR of 3.18% during the forecast period, reaching an estimated USD 8.0 ...

Confluence of modern medicine and technology discussed at PIWOT-2025 in Mumbai: Our Bureau, Mumbai Tuesday, January 28, 2025, 16:15 Hrs [IST] Leading experts from healthcare, medi ...

Kaiser shared data from the phase 1 HELIOS trial that showed stability or improvement in diabetic retinopathy at 1 year after treatment with the implant. Patients also saw improvements in diabetic ...

To avoid disaster, the Government has limits for legal and illegal drugs, so ask your doctor if you’re unsure. But it’s not ...

Stock analysts at StockNews.com began coverage on shares of IRIDEX (NASDAQ:IRIX – Get Free Report) in a report released on Tuesday. The brokerage set a “hold” rating on the medical equipment ...

Ocular inflammation and vision-threatening adverse events to cancer therapies can be mitigated once researchers understand their mechanisms.

Ocular axial growth in pseudophakic eyes of patients operated for monocular infantile cataract: a comparison of operated and fellow eyes measured at surgery and 5 or more years later.

Today Early in the fall, experts might also see more cases of respiratory syncytial virus, Dr. Geeta Sood, assistant professor of medicine and epidemiologist at Johns Hopkins Bayview Medical Center, ...